SIM
AGN

Sentry Investment Management’s Allergan Inc AGN Stock Holding History

Sentry Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-14,184
Closed -$3.02M – 552
2014
Q4 		$3.02M Hold
14,184
– – 0.15% 120
2014
Q3 		$2.53M Sell
14,184
-1,748
-11% -$290K 0.13% 125
2014
Q2 		$2.7M Sell
15,932
-1,168
-7% -$182K 0.14% 124
2014
Q1 		$2.12M Hold
17,100
– – 0.11% 147
2013
Q4 		$1.9M Sell
17,100
-7,300
-30% -$697K 0.1% 156
2013
Q3 		$2.21M Buy
24,400
+4,400
+22% +$395K 0.13% 120
2013
Q2 		$1.69M Buy
+20,000
New +$2.07M 0.1% 111

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Sentry Investment Management's AGN Position: Q1 2015 in Review

Sentry Investment Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 14,184 shares — an estimated $3.02M sold.

Sentry Investment Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $3.02M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Sentry Investment Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Sentry Investment Management sold 14,184 Allergan Inc shares in Q1 2015, an estimated $3.02M.
  • Sentry Investment Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Sentry Investment Management's Allergan Inc position peaked at $3.02M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Sentry Investment Management's 13F filing for Q1 2015, filed 28 May 2015.